Kiev, Ukraine (PRWEB) August 13, 2008
Ekomed LLC, a developer, marketer and manufacturer of over 26 herbal health products announced today that the Company has executed a Letter of Intent to expand its marketing initiatives globally with Zodiac Capital Limited - an investment banking group publicly listed on the NSX in Australia.
Zodiac Capital plans to establish and introduce the marketing relationships and product initiatives that will expand the national Ekomed distribution network in Ukraine to the international markets.
Mr. Pylypchuk, The CEO and Scientific Director of the Company commented on this occasion, "As we continue to witness the enormous plant biodiversity that one can exploit if we know where to look, the future complexity and synergy of natural medicines will be better elucidated - in a future where science and nature are already becoming more reunited. Millions of Ukrainians already know about the benefits of our products and we hope that through working with our new Australian partner we will realize our goal to provide affordable and safe phytoproducts beyond our Ukrainian borders."
Dr. Allen Bain, a Director of Zodiac Capital stated, "We look forward to promoting the natural Ekomed herbal products with their use supported by recent achievements in science and medicine. Ekomed products have already been reported as effective and beneficial in well regarded medical journals and the Ekomed research team continues progressing milestone research. For example, a recent successful Phase II trial on 40 patients with dual HIV/AIDS and tuberculosis infection was reported on June 20 of this year." (http://www.prweb.com/releases/2008/6/prweb1037724.htm).
About Ekomed LLC:
Ekomed LLC is a leading bio-pharmaceutical company located in Kiev, Ukraine and primarily engaged in the research, production, and sales of herbal products. Over 15 years of intensive research and clinical trials have culminated in the approval of the whole range of Ekomed natural, functional supplements by the Ukraine Ministry of Health. Basic and clinical studies conducted at more than 40 research institutes and hospitals in Ukraine have confirmed beneficial properties of Ekomed's phytoconcentrates as safe and effective means for alleviating various ailments. The Company has pioneered botanical products in the Ukraine by setting the standards for regulation of herbal extracts and developing the standardized extracts and ingredients for their own range of herbal nutraceuticals and natural medicinal products. The Company's main products are classified as botanical immunomodulators and functional foods and have proven to be beneficial for conditions including: arthritis, allergies, anemia, autoimmune disorders, diabetes, bronchitis, inflammation, impotence, menopause, HIV/AIDS, varicose veins and hemorrhoids, hepatitis, tuberculosis, influenza, herpes zoster and many others.
CEO and Scientific Director
pylypchuk @ bk.ru
Dr Allen Bain
Zodiac Capital Limited
allen.bain @ zodiaccap.com